Plain-English translation of NCT06646588 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of two medications called and , followed by radiation therapy, for people with esophageal squamous cell carcinoma (a type of esophageal cancer) that has returned or progressed after prior treatment. works by stopping the cancer from developing new blood vessels, while helps your immune system fight cancer cells. Researchers want to see if this medication combination, followed by radiation, can help people whose cancer hasn't responded to earlier treatments.
Standard chemotherapy for advanced esophageal cancer has limited effectiveness, and many patients need better treatment options. While newer immune therapies have helped some patients, researchers are now exploring whether combining this medication with radiation therapy can work even better for people whose cancer has come back or continued to grow.
You likely qualify if…
You likely don't qualify if…
You would receive and as medications, likely given over a period of weeks or months, followed by radiation therapy to your esophagus. You would have regular clinic visits for blood tests, imaging scans, and physical exams to monitor how the treatment is working and check for side effects. The study plans to enroll about 67 people total and is currently recruiting participants.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China